Sarepta Therapeutics, Inc. (SRPT)
17.68
+0.58
(+3.39%)
USD |
NASDAQ |
Oct 19, 14:03
Sarepta Therapeutics Cash from Operations (Annual) : -222.54M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -222.54M |
| December 31, 2024 | -205.79M |
| December 31, 2023 | -500.99M |
| December 31, 2022 | -325.35M |
| December 31, 2021 | -443.17M |
| December 31, 2020 | 107.47M |
| December 31, 2019 | -460.80M |
| December 31, 2018 | -388.66M |
| December 31, 2017 | -232.00M |
| December 31, 2016 | -245.82M |
| December 31, 2015 | -149.46M |
| December 31, 2014 | -128.54M |
| December 31, 2013 | -64.70M |
| December 31, 2012 | -29.69M |
| December 31, 2011 | -23.68M |
| Date | Value |
|---|---|
| December 31, 2010 | -15.21M |
| December 31, 2009 | -8.80M |
| December 31, 2008 | -12.34M |
| December 31, 2007 | -24.68M |
| December 31, 2006 | -20.61M |
| December 31, 2005 | -14.67M |
| December 31, 2004 | -23.78M |
| December 31, 2003 | -17.48M |
| December 31, 2002 | -20.26M |
| December 31, 2001 | -12.82M |
| December 31, 2000 | -9.129M |
| December 31, 1999 | -7.561M |
| December 31, 1998 | -6.736M |
| December 31, 1997 | -3.006M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Moderna, Inc. | -1.873B |
| Arrowhead Pharmaceuticals, Inc. | 179.55M |
| Beam Therapeutics, Inc. | -345.10M |
| Rocket Pharmaceuticals, Inc. | -190.05M |
| Intellia Therapeutics, Inc. | -394.74M |